-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on NRx Pharmaceuticals, Inc. (NRXP)
-
-
-
-
-
-
-
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports First Quarter 2025 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
NRx Pharmaceuticals (NASDAQ:NRXP) Reports Third Quarter and Year to Date 2024 Financial Results and Provides Business Update
-
-
-
-
-
-
-
NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) to Report First Quarter 2024 Financial Results on May 14, 2024
-
-
-
-
-
-
-
UPDATE: NRx Pharmaceuticals (NASDAQ: NRXP) to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024
-
-
-
-
-
-
-
NRx Pharmaceuticals to Report Second Quarter 2023 Financial Results on August 14, 2023
-
-
-
-
-
-
-
NRx Pharmaceuticals (NRXP) Reports Q3, Provides Business Update
-
1,223,694 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

